Lori Marie Bigi

Lori Bigi practices at UPMC Passavant-McCandless in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center.

Lori Bigi's NPI, 1093787137, was assigned on February 3, 2006. Lori Bigi graduated from Perelman School of Med at the University of Pennsylvania in 1991. Lori Bigi holds Pennsylvania license MD052825L.

Lori Bigi's primary practice is UPMC Passavant-McCandless, at 9100 Babcock Boulevard, Pittsburgh, PA 15237 in Allegheny County. The practice phone is (412) 367-6700.

Lori Bigi's primary practice is UPMC Passavant-McCandless in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center. Lori Bigi is also affiliated with UPMC Presbyterian. The medical group on file is University of Pittsburgh Physicians, Department of Radiology. Dmand AI also links Lori Bigi to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Lori Bigi practices, 7 sites in all. Vendor and product names are available with a free account.

Internal medicine is Lori Bigi's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Lori Bigi is licensed in Pennsylvania.

CMS data shows 510 Medicare services from Lori Bigi across 10 procedure codes in 2024, for 203 Medicare patients. Medicare paid $31,114 for them. Every service was in an office.

CMS counts 203 Medicare patients who saw Lori Bigi in 2024. The largest group is 65 to 74, with 123 patients. 75% of them have high cholesterol, and 67% have high blood pressure. Their average risk score is 0.98, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Lori Bigi's median patient age at 68, with 77% women.

In 2024, Lori Bigi wrote 7,737 Medicare Part D claims for 646 patients. 89% of them were for generic drugs. CMS names the drug for 7,060 of them, across 122 drugs with 11 or more claims each, at $496,674 in total drug cost. In 2023, CMS named 5,011 claims across 107 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Lori Bigi for performance year 2024, reported as part of a group. Lori Bigi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Lori Bigi from 1 drug or device company in 2023. Food and beverage make up the largest share, 100% of the total. Pfizer Inc. paid the most, $19.

Lori Bigi graduated from Perelman School of Med at the University of Pennsylvania in 1991.